CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

Showing 5 of 5 entries

View as:

Phase: N/A Priority: Normal

NCT ID: NCT03775278 Org: User:

Start: 12/17/18 End: 04/07/20 Due: 04/07/21

Phase: N/A Priority: Normal

NCT ID: NCT03586908 Org: User:

Start: 02/04/18 End: 03/09/18 Due: 03/09/19

Phase: N/A Priority: Normal

NCT ID: NCT04863365 Org: User:

Start: 11/30/21 End: 11/30/23 Due: 11/30/24

Phase: N/A Priority: Normal

NCT ID: NCT03627845 Org: User:

Start: 08/02/18 End: 01/08/20 Due: 01/08/21

Phase: N/A Priority: Normal

NCT ID: NCT03106532 Org: User:

Start: 03/06/17 End: 05/02/18 Due: 05/02/19

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects	NCT03775278	pH Pharma	user2@example.com	None	2018-12-17	2020-04-07	2021-04-07	-	-	2025-07-14
PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects	NCT03586908	pH Pharma	user2@example.com	None	2018-02-04	2018-03-09	2019-03-09	-	-	2025-07-14
A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension	NCT04863365	pH Pharma	user2@example.com	None	2021-11-30	2023-11-30	2024-11-30	-	-	2025-07-14
A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects	NCT03627845	pH Pharma	user2@example.com	None	2018-08-02	2020-01-08	2021-01-08	-	-	2025-07-14
Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma	NCT03106532	pH Pharma	user2@example.com	None	2017-03-06	2018-05-02	2019-05-02	-	-	2025-07-14